Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly

This page shows the latest Eli Lilly news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO

Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO

Eli Lilly has presented data for the potential new use of its CDK4/6 inhibitor Verzenio in high-risk early breast cancer patients at the 2021 American Society of Clinical Oncology ... Previously, Lilly reported initial results from the monarchE trial,

Latest news

More from news
Approximately 142 fully matching, plus 629 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    Eli Lilly, Bristol-Myers Squibb and Pfizer also have multiple development programmes that are paused or delayed.

  • Working together against COVID-19 Working together against COVID-19

    A number of top pharma companies are included in the newly formed partnership, the COVID-19 Therapeutics Accelerator, including Eli Lilly, J&J, Merck, Novartis, Pfizer and Sanofi.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    A pack of other antibody programmes involving companies including Amgen, AstraZeneca, Eli Lilly and GlaxoSmithKline is following closely behind, with multiple clinical trials scheduled to start over the summer.

More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 7 fully matching, plus 33 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....